We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Top Sells

Rank Stock Value
1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$49.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$41.6M
3
ARQL
Arqule Inc
ARQL
+$26.5M
4
ARWR icon
Arrowhead Research
ARWR
+$24.9M
5
MRK icon
Merck
MRK
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
76
DELISTED
Acceleron Pharma
XLRN
$25.6M 0.27%
482,530
-68,970
-13% -$3.14M
INCY icon
77
Incyte
INCY
$23.5B
$25.3M 0.27%
290,003
-4,188
-1% -$358K
AWK icon
78
American Water Works
AWK
$26.3B
$24.2M 0.26%
197,019
+84,813
+76% +$10.3M
CBRE icon
79
CBRE Group
CBRE
$40.8B
$24M 0.26%
391,687
+71,381
+22% +$3.95M
RETA
80
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$23.6M 0.25%
115,400
-80,800
-41% -$14.7M
ADSW
81
DELISTED
Advanced Disposal Services Inc
ADSW
$23.5M 0.25%
714,955
+170,499
+31% +$5.59M
BIDU icon
82
Baidu
BIDU
$35.8B
$23.4M 0.25%
185,457
+68,198
+58% +$7.75M
TXN icon
83
Texas Instruments
TXN
$255B
$22.9M 0.25%
178,834
-1,008
-0.6% -$124K
ISRG icon
84
Intuitive Surgical
ISRG
$121B
$22.7M 0.24%
115,398
-20,307
-15% -$3.8M
LOW icon
85
Lowe's Companies
LOW
$116B
$22.5M 0.24%
187,776
+34,277
+22% +$3.92M
AMAT icon
86
Applied Materials
AMAT
$426B
$22.4M 0.24%
367,587
+19,026
+5% +$1.07M
ALNY icon
87
Alnylam Pharmaceuticals
ALNY
$36.3B
$22M 0.24%
190,732
+659
+0.3% +$65.7K
TRMB icon
88
Trimble
TRMB
$12.3B
$21.9M 0.24%
526,510
+117,521
+29% +$4.67M
OLED icon
89
Universal Display
OLED
$3.71B
$21.7M 0.23%
105,292
+33,455
+47% +$6.32M
HLT icon
90
Hilton Worldwide
HLT
$74B
– –
-117,926
Closed -$11.8M
ZION icon
91
Zions Bancorporation
ZION
$10.1B
$21.5M 0.23%
413,738
+147,263
+55% +$7.15M
SRPT icon
92
Sarepta Therapeutics
SRPT
$1.66B
$21.3M 0.23%
165,100
-27,500
-14% -$2.78M
EL icon
93
Estee Lauder
EL
$29B
$21.1M 0.23%
102,267
+5,486
+6% +$1.07M
SCCO icon
94
Southern Copper
SCCO
$141B
$21.1M 0.23%
535,581
+267,521
+100% +$9.31M
SPLK
95
DELISTED
Splunk Inc
SPLK
$21.1M 0.23%
140,665
+7,448
+6% +$978K
APD icon
96
Air Products & Chemicals
APD
$66.3B
$20.9M 0.22%
89,111
+20,828
+31% +$4.7M
BLUE
97
DELISTED
bluebird bio
BLUE
$20.9M 0.22%
18,361
+5,306
+41% +$5.77M
ONC
98
BeOne Medicines Ltd
ONC
$33.8B
$20.8M 0.22%
125,486
-50,266
-29% -$8.35M
CMCSA icon
99
Comcast
CMCSA
$79.1B
$20.4M 0.22%
454,554
+72,428
+19% +$3.22M
WFC icon
100
Wells Fargo
WFC
$261B
$20.4M 0.22%
378,994
-16,948
-4% -$888K
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.